VIR BIOTECHNOLOGY INC (VIR)

US92764N1028 - Common Stock

9.37  +0.11 (+1.19%)

After market: 9.0512 -0.32 (-3.4%)

Buy % Consensus

77

ChartMill assigns a Buy % Consensus number of 77% to VIR. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 34.53. This target is 268.56% above the current price.
VIR was analyzed by 13 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about VIR.
In the previous month the buy percentage consensus was at a similar level.
VIR was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 9.3715.1521.4234.53115.50 - 61.69% 128.60% 268.56% 1,132.66%
Up and Down Grades
Date Firm Action Rating
2024-11-04 Barclays Maintains Overweight -> Overweight
2024-11-04 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-01 Needham Reiterate Buy -> Buy
2024-08-20 HC Wainwright & Co. Reiterate Buy -> Buy
2024-08-02 Barclays Maintains Overweight -> Overweight
2024-06-06 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2024-06-05 Needham Maintains Buy -> Buy
2024-06-05 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-24 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-07 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-03 Needham Reiterate Buy -> Buy
2024-05-03 JP Morgan Maintains Neutral -> Neutral
2024-03-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-02-23 JP Morgan Maintains Neutral -> Neutral
2024-02-14 HC Wainwright & Co. Maintains Buy -> Buy
2024-01-29 JP Morgan Downgrade Overweight -> Neutral
2024-01-23 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-03 Needham Maintains Buy -> Buy
2023-09-08 B of A Securities Downgrade Buy -> Neutral
2023-08-07 HC Wainwright & Co. Maintains Buy -> Buy
2023-08-04 Needham Reiterate Buy -> Buy
2023-07-21 Barclays Maintains Overweight -> Overweight
2023-07-21 Goldman Sachs Maintains Buy -> Buy
2023-07-21 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-07-20 Needham Maintains Buy -> Buy
2023-07-20 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-05 Needham Reiterate Buy
2023-04-19 Needham Reiterate Buy
2023-04-04 Morgan Stanley Maintains Equal-Weight
2023-03-06 JP Morgan Upgrade Neutral -> Overweight